Children grow faster during the school year, study finds
Experts from the Baylor College of Medicine in Texas found Year 1 pupils shot up an extra half a millimetre a month on average between September and April. (Source: the Mail online | Health)
Source: the Mail online | Health - May 11, 2022 Category: Consumer Health News Source Type: news
Op-ed: How the pandemic exposed shortcomings in primary care
Workers in all industries are experiencing unprecedented challenges to maintaining optimal health, said James McDeavitt, executive vice president and dean of clinical affairs at Baylor College of Medicine in Houston. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 9, 2022 Category: Pharmaceuticals Source Type: news
Dr. Annette Regan of the University of San Francisco School of Nursing...
Annette Regan, PhD, of the USF School of Nursing and Health Professions public health program, along with co-investigators from UCLA and Baylor College of Medicine, has received a $1.27 million award...(PRWeb April 13, 2022)Read the full story at https://www.prweb.com/releases/dr_annette_regan_of_the_university_of_san_francisco_school_of_nursing_and_health_professions_receives_1_27_million_from_nih_to_study_covid_19_vaccination_in_pregnancy/prweb18618608.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 13, 2022 Category: Pharmaceuticals Source Type: news
Study involving investigators from Mayo Clinic, Baylor College of Medicine applies drug-gene testing to improve patient care and reports outcomes
ROCHESTER, Minn. ― In a newly published study appearing in Genetics in Medicine, investigators from Mayo Clinic and Baylor College of Medicine found that targeted genomic information can play an important role in drug prescribing practices. The results from the "Right Drug, Right Dose, Right Time: Using Genomic Da ta to Individualize Treatment" (RIGHT 10K) study strongly suggest that preemptive testing could benefit nearly every patient at some point, particularly when the testing extends beyond DNA… (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - March 22, 2022 Category: Research Source Type: news
Can Alternative Medicine Help People With Asthma?
During her time working with underserved communities in southwest Philadelphia, Maureen George encountered many unconventional asthma treatments, including the use of homemade botanical teas or tonics.
“You find there’s a rich history of using these home remedies to manage asthma, in part because accessing traditional medicine has been difficult or resulted in disappointing interactions,” says George, a professor of nursing at Columbia University Medical Center in New York City.
George has published research on asthma self-management and the use of complementary or alternative medicine. Even when people d...
Source: TIME: Health - March 11, 2022 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized healthscienceclimate Source Type: news
Nasal Vaccines Could Help Stop COVID-19 From Spreading —If Scientists Can Get Them Right
When SARS-CoV-2, the virus that causes COVID-19, infiltrates the body, it typically enters through the nose or mouth, then takes root and begins replicating.
But what if it could never get a foothold in the upper airways? That’s the promise of nasal COVID-19 vaccines, which are meant to prevent infection by blocking the virus at its point of entry.
There is not yet a nasal COVID-19 vaccine available in the U.S.—and it’s not clear if or when there will be—but multiple research teams in the U.S., including the National Institute of Allergy and Infectious Diseases, and abroad are working on them. Russi...
Source: TIME: Health - February 15, 2022 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Pandemic Anxiety Is Fueling OCD Symptoms —Even for People Without the Disorder
Rosalyn (not her real name) had no idea what she intended to do with the three boxes of spaghetti she had just dumped into her shopping cart. She didn’t want them—she certainly didn’t need them—but never mind, she had to buy them. And the spaghetti boxes weren’t the only unwanted items she picked up in the grocery store that day during the first year of the COVID-19 pandemic. If she so much as grazed one item while she was reaching for another, into the shopping cart it went.
“Everything my hand touched I had to buy,” she said. “I didn’t feel I had a choice. There was t...
Source: TIME: Health - January 20, 2022 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Texas scientists ’ new Covid-19 vaccine is cheaper, easier to make and patent-free
Dr Maria Bottazzi says their vaccine, called Corbevax, is unique because they do not intend to patent itA new Covid-19 vaccine is being developed by Texas scientists using a decades-old conventional method that will make the production and distribution cheaper and more accessible for countries most affected by the pandemic and where new variants are likely to originate due to low inoculation rates.The team, led by Drs Peter Hotez and Maria Bottazzi from the Texas Children ’s Hospital Center for Vaccine Development at Baylor College of Medicine, has been developing vaccine prototypes for Sars and Mers since 2011, which th...
Source: Guardian Unlimited Science - January 15, 2022 Category: Science Authors: Erum Salam Tags: Texas Coronavirus Vaccines and immunisation US news World news Science Source Type: news
What is Biological E, the Indian company producing Corbevax?
The Hyderabad-based company says the vaccine will provide ‘sustainable access to low- and middle-income countries’The Indian biotechnology and biopharmaceutical company Biological E has produced the country ’s first locally developed Covid-19 vaccine in partnership with the Texas Children’s Hospital Center for Vaccine Development at Baylor College of Medicine.The Hyderabad-based company has already produced 150m doses of the vaccine, called Corbevax, and will produce 100m doses each month beginning in February. It is expected that 1bn doses will be produced by the end of 2022 – just shy of India’s nearly 1.4-bi...
Source: Guardian Unlimited Science - January 15, 2022 Category: Science Authors: Erum Salam Tags: Vaccines and immunisation Coronavirus India World news Science Infectious diseases Source Type: news
Health care 2.0: Improving the Next Generation of Health care During and Beyond the Pandemic (live webinar recap)
On Tuesday, December 14, 2021 HBJ President& Publisher Bob Charlet sat down, virtually, with our panel of experts to address how the current public health crisis is changing our outlook on business, medicine and the economy and how health systems and companies across the country are improving the next generation of health care during and beyond the pandemic.
Panelist: Dr. Doug Lawson, CEO, St. Luke’s Health; Dr. Paul Klotman, president and CEO, Baylor College of Medicine; Dr. Joseph G.… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - December 31, 2021 Category: American Health Source Type: news
Texas Children's, Baylor College of Medicine to launch Covid vaccine in India
Texas Children's Hospital Center for Vaccine Development began working on a SARS vaccine in 2011 and used the critical scientific information they compiled then to develop a vaccine for the virus that causes Covid-19. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - December 28, 2021 Category: American Health Authors: Sara Samora Source Type: news
Biden Pivots to Home Tests to Confront Omicron Surge
WASHINGTON (AP) — Fighting the omicron variant surging through the country, President Joe Biden announced the government will provide 500 million free rapid home-testing kits, increase support for hospitals under strain and redouble vaccination and boosting efforts.
At the White House on Tuesday, Biden detailed major changes to his COVID-19 winter plan, his hand forced by the fast-spreading variant, whose properties are not yet fully understood by scientists. Yet his message was clear that the winter holidays could be close to normal for the vaccinated while potentially dangerous for the unvaccinated.
His pleas are n...
Source: TIME: Health - December 21, 2021 Category: Consumer Health News Authors: AP/ JOSH BOAK, RICARDO ALONSO-ZALDIVAR and COLLEEN LONG Tags: Uncategorized COVID-19 Source Type: news
Anne Rimoin named to new Gordon –Levin Chair in Infectious Diseases and Public Health
Anne Rimoin, an internationally recognized expert on emerging infections, global health, infectious disease surveillance systems and vaccinations who has been engaged in pandemic preparedness and response work for more than two decades, has been appointed to the newly established Gordon –Levin Endowed Chair in Infectious Diseases and Public Health at theUCLA Fielding School of Public Health.The chair was established by a $2 million gift from Tom and Edna Gordon and the Don S. Levin Trust to support the teaching and research activities of a faculty member with expertise in the epidemiology, transmission and control of inf...
Source: UCLA Newsroom: Health Sciences - November 9, 2021 Category: Universities & Medical Training Source Type: news
Texas-India vaccine diplomacy announces COVID-19 vaccine for $1.5 per dose
By Seema Hakhu Kachru Houston, The Texas-India vaccine diplomacy, a collaboration for shared global health between Indian pharmaceutical company Biological E and the Texas Children's Hospital and Baylor College of Medicine, has led to the development of a cost-efficient vaccine against COVID-19 for USD 1.50 per dose, according to a top American scientist. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 1, 2021 Category: Pharmaceuticals Source Type: news
St. Luke's Health, Cigna still in negotiation stalemate as end of contract looms
Dr. Doug Lawson, CEO of St. Luke's Health, said he intends to reach out directly to Cigna this week in an attempt to facilitate a negotiation to keep the nearly 70,000 patients in the Houston region in-network with St. Luke's Health and Baylor College of Medicine. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - October 27, 2021 Category: Health Management Authors: Chris Mathews Source Type: news
